A large, global pharmaceutical sponsor needed to scale its data sharing as part of its effort to drive greater advancements in patient health.
This objective required anonymizing a backlog of clinical trial structured patient data not yet published for researchers.
Many of these studies were large and complex. Some of the studies covered a pool of trials over 30,000 participants and 5,000 variables, and others with multiple extension studies.
The drug sponsor leveraged Privacy Analytics’ service to anonymize the studies using a proven statistical, risk-based methodology.
- Over 100 datasets were delivered in two quarters (7 months), each with statistical proof of compliance under the General Data Protection Regulation (GDPR) and other applicable regulations.
- Data utility was maximized to accelerated high-priority analytics projects with health research partners. Privacy Analytics implemented tailored data utility optimizations to address specific researcher needs.
- In addition to the initial efficiency gains, the sponsor also realized more than 20% in cost savings over time.
Privacy Analytics can help your company quickly anonymize structured patient data.